Biomarkers for Diabetic Foot Ulcers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to identify specific biomarkers that can predict the likelihood of healing in diabetic foot ulcers (open sores on the foot). Understanding these markers may help doctors make better treatment decisions and improve future therapies. People with diabetes who have an open wound on their foot and are willing to provide samples and data might be suitable for this study. As an unphased study, this trial offers participants the chance to contribute to groundbreaking research that could significantly enhance treatment strategies for diabetic foot ulcers.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to identify biomarkers for active diabetic foot ulcers, which could revolutionize how we approach treatment. Unlike current methods that primarily focus on wound care and infection control, uncovering specific biomarkers could lead to earlier detection and personalized treatment plans. This approach has the potential to improve healing rates and prevent serious complications by tailoring interventions to the unique biological profile of each patient.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Biomarker Testing
Participants undergo biomarker testing to identify diabetic foot ulcers with a higher potential for healing
Follow-up
Participants are monitored for wound healing and recurrence, with assessments at weeks 52 and 78
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator